Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787995 · ClinicalTrials.gov registry record
A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)
A clinical trial, sponsored by BioMarin Pharmaceutical.
- Terminated
- Registry status
- 353
- Enrollment target
NCT00787995 is a clinical trial that was terminated before completion, run by BioMarin Pharmaceutical. The registered enrollment target is 353 participants.
The verdict
NCT00787995 was terminated before completion, sponsored by BioMarin Pharmaceutical.
- TERMINATED
- Registry status
- 353 participants
- Enrollment target
Study Summary
This multicenter, multinational, longitudinal study will quantify endurance and respiratory function in subjects diagnosed with MPS IVA and will better characterize the spectrum of symptoms and biochemical abnormalities in MPS IVA disease over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00787995
The ClinicalTrials.gov registry entry for NCT00787995 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 353 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMarin Pharmaceutical, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00787995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00787995 about?
NCT00787995 is a clinical study titled "A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)". This multicenter, multinational, longitudinal study will quantify endurance and respiratory function in subjects diagnosed with MPS IVA and will better characterize the spectrum of symptoms and biochemical abnormalities in MPS IVA disease over time.
What is the current status of trial NCT00787995?
This trial is currently terminated. The enrollment target is 353 participants. The study started on 2008-10. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT00787995?
This trial is sponsored by BioMarin Pharmaceutical, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.